MarketCapTrends
CRNX
Crinetics Pharmaceuticals Inc. (CRNX)
NASDAQ · Healthcare

Crinetics Pharmaceuticals Inc. Total Liabilities 2016–2025

Crinetics Pharmaceuticals Inc. annual/quarterly total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Crinetics Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 134.2M, a 22.21% increase year-over-year.
  • Crinetics Pharmaceuticals Inc. total liabilities for 2025 were 134.2M, a 22.21% increase from 2024.
  • Crinetics Pharmaceuticals Inc. total liabilities for 2024 were 109.8M, a 14.07% increase from 2023.
  • Crinetics Pharmaceuticals Inc. total liabilities for 2023 were 96.2M, a 168.49% increase from 2022.
  • Crinetics Pharmaceuticals Inc. total liabilities for 2022 were 35.8M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Crinetics Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $)
2025$134
2024$110
2023$96
2022$36
2021$19
2020$15
2019$13
2018$11
2017$1
Crinetics Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$134
2024-12-31$110
2023-12-31$96
2022-12-31$36
2021-12-31$19
2020-12-31$15
2019-12-31$13
2018-12-31$11
2017-12-31$1

Crinetics Pharmaceuticals Inc. Total Liabilities — FAQ

Crinetics Pharmaceuticals Inc. (CRNX) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CRNX's total liabilities history?

The chart and table above show Crinetics Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.